• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型重组卡介苗共表达 Ag85B、ESAT-6 和小鼠 TNF-α 可显著增强 C57BL/6 小鼠的细胞免疫和体液免疫应答。

Novel recombinant BCG coexpressing Ag85B, ESAT-6 and mouse TNF-alpha induces significantly enhanced cellular immune and antibody responses in C57BL/6 mice.

机构信息

State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai 200433, China.

出版信息

Microbiol Immunol. 2010 Aug;54(8):435-41. doi: 10.1111/j.1348-0421.2010.00232.x.

DOI:10.1111/j.1348-0421.2010.00232.x
PMID:20646207
Abstract

The recent emergence of multidrug-resistant and extensively drug-resistant strains of Mtb and the epidemic of TB in populations co-infected with human immunodeficiency virus demonstrate that TB remains a leading infectious disease. Moreover, the failure of BCG to protect against this disease indicates that new vaccines against TB are urgently needed. Experimental evidence has revealed that TNF plays a major role in host defense against Mtb in both active and latent phases of infection. Release of TNF, which would induce mycobacteria-mediated macrophage apoptosis and thus reduce the spread of mycobacteria, is one of the most important and early responses of macrophages challenged with Mtb. In order to identify the usefulness of TNF in improving the effectiveness of TB vaccine, in the current study a novel rBCG strain expressing the fusion gene of Ag85B-Esat6-TNF-alpha in BCG Danish strain was constructed, and its ability to induce an immune response in C57BL/6 mice evaluated. It was found that immunization with strains of rBCG-Ag85B-Esat6-TNF-alpha can induce a stronger immune response than does immunization with rBCG-Ag85B-Esat6 or parental BCG. The results indicate that rBCG-Ag85B-Esat6-TNF-alpha is a promising candidate for further study.

摘要

最近,耐多药和广泛耐药结核分枝杆菌菌株的出现以及人类免疫缺陷病毒感染人群中的结核病例流行表明,结核病仍然是一种主要的传染病。此外,卡介苗未能预防这种疾病表明,迫切需要新的结核病疫苗。实验证据表明,在感染的活动期和潜伏期中,TNF 在宿主对结核分枝杆菌的防御中发挥主要作用。TNF 的释放会诱导分枝杆菌介导的巨噬细胞凋亡,从而减少分枝杆菌的传播,这是受到结核分枝杆菌挑战的巨噬细胞最重要和最早的反应之一。为了确定 TNF 在提高结核病疫苗有效性方面的作用,在本研究中,构建了一种新型 rBCG 菌株,该菌株在丹麦卡介苗菌株中表达了 Ag85B-Esat6-TNF-α 的融合基因,并评估了其在 C57BL/6 小鼠中诱导免疫反应的能力。结果发现,rBCG-Ag85B-Esat6-TNF-α 菌株的免疫接种可以诱导比 rBCG-Ag85B-Esat6 或亲本 BCG 更强的免疫反应。结果表明,rBCG-Ag85B-Esat6-TNF-α 是进一步研究的有前途的候选者。

相似文献

1
Novel recombinant BCG coexpressing Ag85B, ESAT-6 and mouse TNF-alpha induces significantly enhanced cellular immune and antibody responses in C57BL/6 mice.新型重组卡介苗共表达 Ag85B、ESAT-6 和小鼠 TNF-α 可显著增强 C57BL/6 小鼠的细胞免疫和体液免疫应答。
Microbiol Immunol. 2010 Aug;54(8):435-41. doi: 10.1111/j.1348-0421.2010.00232.x.
2
Novel recombinant BCG coexpressing Ag85B, ESAT-6 and Rv2608 elicits significantly enhanced cellular immune and antibody responses in C57BL/6 mice.新型重组卡介苗共表达 Ag85B、ESAT-6 和 Rv2608 可显著增强 C57BL/6 小鼠的细胞免疫和抗体应答。
Scand J Immunol. 2012 Sep;76(3):271-7. doi: 10.1111/j.1365-3083.2012.02726.x.
3
Fusion protein Ag85B-MPT64(190-198)-Mtb8.4 has higher immunogenicity than Ag85B with capacity to boost BCG-primed immunity against Mycobacterium tuberculosis in mice.融合蛋白Ag85B-MPT64(190-198)-Mtb8.4比Ag85B具有更高的免疫原性,能够增强卡介苗致敏的小鼠对结核分枝杆菌的免疫力。
Vaccine. 2009 Oct 19;27(44):6179-85. doi: 10.1016/j.vaccine.2009.08.018. Epub 2009 Aug 25.
4
Recombinant BCG coexpressing Ag85B, ESAT-6 and Rv3620c elicits specific Th1 immune responses in C57BL/6 mice.共表达Ag85B、ESAT-6和Rv3620c的重组卡介苗在C57BL/6小鼠中引发特异性Th1免疫反应。
Microb Pathog. 2014 Apr-May;69-70:53-9. doi: 10.1016/j.micpath.2014.03.011. Epub 2014 Apr 12.
5
Efficacy of recombinant bacille Calmette-Guérin vaccine secreting interleukin-15/antigen 85B fusion protein in providing protection against Mycobacterium tuberculosis.分泌白细胞介素-15/抗原85B融合蛋白的重组卡介苗在提供抗结核分枝杆菌保护方面的疗效
J Infect Dis. 2008 May 1;197(9):1263-74. doi: 10.1086/586902.
6
Recombinant BCG coexpressing Ag85B, ESAT-6 and mouse-IFN-gamma confers effective protection against Mycobacterium tuberculosis in C57BL/6 mice.共表达Ag85B、ESAT-6和小鼠干扰素-γ的重组卡介苗对C57BL/6小鼠的结核分枝杆菌感染具有有效的保护作用。
FEMS Immunol Med Microbiol. 2007 Dec;51(3):480-7. doi: 10.1111/j.1574-695X.2007.00322.x. Epub 2007 Oct 4.
7
Evaluation of a new recombinant BCG which contains mycobacterial antigen ag85B-mpt64(190-198)-mtb8.4 in C57/BL6 mice.在C57/BL6小鼠中对一种含有分枝杆菌抗原ag85B-mpt64(190 - 198)-mtb8.4的新型重组卡介苗的评估。
Scand J Immunol. 2008 Feb;67(2):133-9. doi: 10.1111/j.1365-3083.2007.02048.x.
8
Recombinant Mycobacterium smegmatis expressing an ESAT6-CFP10 fusion protein induces anti-mycobacterial immune responses and protects against Mycobacterium tuberculosis challenge in mice.表达 ESAT6-CFP10 融合蛋白的重组耻垢分枝杆菌诱导抗分枝杆菌免疫应答,并保护小鼠免受结核分枝杆菌攻击。
Scand J Immunol. 2010 Oct;72(4):349-57. doi: 10.1111/j.1365-3083.2010.02448.x.
9
Improved immunogenicity of recombinant Mycobacterium bovis bacillus Calmette-Guérin strains expressing fusion protein Ag85A-ESAT-6 of Mycobacterium tuberculosis.表达结核分枝杆菌融合蛋白 Ag85A-ESAT-6 的重组牛型分枝杆菌卡介苗菌株的免疫原性增强。
Scand J Immunol. 2010 Oct;72(4):332-8. doi: 10.1111/j.1365-3083.2010.02444.x.
10
A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection.一种表达多阶段抗原 Ag85B 和 HspX 的减毒活卡介苗疫苗可提供针对结核分枝杆菌感染的卓越保护。
Appl Microbiol Biotechnol. 2015 Dec;99(24):10587-95. doi: 10.1007/s00253-015-6962-x. Epub 2015 Sep 12.

引用本文的文献

1
Recombinant BCG to Enhance Its Immunomodulatory Activities.重组卡介苗以增强其免疫调节活性。
Vaccines (Basel). 2022 May 23;10(5):827. doi: 10.3390/vaccines10050827.
2
Recombinant BCGs for tuberculosis and bladder cancer.结核和膀胱癌的重组卡介苗。
Vaccine. 2021 Dec 8;39(50):7321-7331. doi: 10.1016/j.vaccine.2021.09.040. Epub 2021 Sep 27.
3
Animal Models of Tuberculosis Vaccine Research: An Important Component in the Fight against Tuberculosis.结核病疫苗研究的动物模型:抗击结核病的重要组成部分。
Biomed Res Int. 2020 Jan 2;2020:4263079. doi: 10.1155/2020/4263079. eCollection 2020.
4
The current status, challenges, and future developments of new tuberculosis vaccines.新型结核疫苗的现状、挑战和未来发展。
Hum Vaccin Immunother. 2018 Jul 3;14(7):1697-1716. doi: 10.1080/21645515.2018.1458806. Epub 2018 May 14.
5
Assessment of recombinant plasmid expressing fusion antigen Ag85B-Rv3425 in management of acute tuberculosis infection in mice.表达融合抗原Ag85B-Rv3425的重组质粒在小鼠急性结核感染治疗中的评估
Exp Ther Med. 2018 Mar;15(3):3034-3039. doi: 10.3892/etm.2018.5785. Epub 2018 Jan 23.
6
Next-Generation Vaccines Based on Bacille Calmette-Guérin.基于卡介苗的新一代疫苗。
Front Immunol. 2018 Feb 5;9:121. doi: 10.3389/fimmu.2018.00121. eCollection 2018.
7
Bis-biguanide dihydrochloride inhibits intracellular replication of M. tuberculosis and controls infection in mice.双胍二盐酸盐抑制结核分枝杆菌的细胞内复制,并控制小鼠感染。
Sci Rep. 2016 Sep 7;6:32725. doi: 10.1038/srep32725.
8
Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection.过表达Ag85A蛋白的牛分枝杆菌卡介苗对结核分枝杆菌气溶胶感染引发的免疫原性和保护效力评估
Front Cell Infect Microbiol. 2016 Jan 28;6:3. doi: 10.3389/fcimb.2016.00003. eCollection 2016.
9
Applications of bacillus Calmette-Guerin and recombinant bacillus Calmette-Guerin in vaccine development and tumor immunotherapy.卡介苗及重组卡介苗在疫苗研发和肿瘤免疫治疗中的应用。
Expert Rev Vaccines. 2015;14(9):1255-75.
10
Tuberculosis vaccine research in China.中国的结核病疫苗研究。
Emerg Microbes Infect. 2012 Jul;1(7):e7. doi: 10.1038/emi.2012.3. Epub 2012 Jul 25.